Clinical Trials
2 trialsNCT04219319 2022-08-16
LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
Phase 1 Terminated
NCT04973527 2022-08-16
LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor
Beijing Boren Hospital
Phase 1 Terminated